Parkinson's disease: premotor clinico-pathological correlations.
about
Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and DiagnosisInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseNon-Linear EMG Parameters for Differential and Early Diagnostics of Parkinson's Disease.Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognitionEnvironmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in miceMood, memory and movement: an age-related neurodegenerative complex?Is heart rate variability related to gait impairment in patients with Parkinson's disease? A pilot study.Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.Short and valid assessment of apraxia in Parkinson's disease.Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease.Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.Sleep and non-motor symptoms in Parkinson's disease.Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson's disease.Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder.Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson's disease.Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential.Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
P2860
Q28384572-C8877764-B062-40BA-A178-A7F96F14DC2DQ28391762-EC472BA2-03C6-4DE2-8244-AF7460BA30B2Q30449049-34BD2C2E-A4FF-4E46-953D-C8395C702B6EQ30482965-518CE184-3CC1-4B99-8235-3E565DD31C97Q30528818-C0E6C057-02F6-4A43-A5BC-CB1287C41E3DQ33554878-15F0A4FD-E0B9-45A0-987C-73164475EB69Q33585003-5B98DC7D-CFDC-4B9C-940E-1BCF69584CFDQ33773655-E9BC55C2-6E50-4D8E-ADF2-3CA81B5C47DFQ35039248-702E0006-8824-4787-8E84-0D9F73CBB4E8Q35474565-AC59E5E6-072B-4183-B7E9-FE6322E9E3AAQ35667600-3910F652-87F6-43F9-84B6-242E1E310AEFQ36104787-F73213DD-1A45-4E85-BF82-2D5E1D0E7029Q36351543-12FCC832-D3DA-4B9C-959E-6DE3259D7A0DQ36384748-EBC82CAF-DE22-401B-A298-5CBCA9E58975Q36725295-9E2C899D-F10D-4EA3-82DE-EBCC3146C08DQ36928061-85FE554F-2D93-4385-9CC4-9DE423F5E414Q37301904-753CE546-58CC-4BE2-9C9D-7C3D74EA9FC3Q41917715-607C3045-21CD-4431-830B-214BEA5261F9Q42108095-D3E53C94-7835-4605-B7C0-0427AEAE440EQ42126269-74782630-6337-4E6E-B953-577F8E0AFA49Q43076967-45BCB7A0-1EBB-454E-8C81-3A700E6AAC32Q47111758-B8021E3E-6B8E-4165-A34D-93581C6D0C57Q49490658-C1D0EE3B-5DCA-4073-BF6F-D16386AC6DC7
P2860
Parkinson's disease: premotor clinico-pathological correlations.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Parkinson's disease: premotor clinico-pathological correlations.
@ast
Parkinson's disease: premotor clinico-pathological correlations.
@en
type
label
Parkinson's disease: premotor clinico-pathological correlations.
@ast
Parkinson's disease: premotor clinico-pathological correlations.
@en
prefLabel
Parkinson's disease: premotor clinico-pathological correlations.
@ast
Parkinson's disease: premotor clinico-pathological correlations.
@en
P1476
Parkinson's disease: premotor clinico-pathological correlations.
@en
P2093
P304
P577
2006-01-01T00:00:00Z